☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Cardiff Oncology
Cardiff Oncology Reports Results for Onvansertib in P-II Trial for the Treatment of Colorectal Cancer
March 1, 2024
PharmaShots Weekly Snapshots (June 07 - 11, 2021)
June 11, 2021
PharmaShots' Key Highlights of First Quarter 2021
April 4, 2021
PharmaShots Interview: Cardiff Oncology's Mark Erlander Shares Insight on the P-I Data of Onvansertib for Metastatic Colorectal Ca...
March 31, 2021
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)
January 22, 2021
Load more...
Back to Home
